Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adaptimmune Therapeutics plc - American Depositary Shares (NQ:ADAP)

0.2060 -0.0140 (-6.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,968,273
Open 0.2371
Bid (Size) 0.2098 (1)
Ask (Size) 0.2099 (14)
Prev. Close 0.2200
Today's Range 0.2026 - 0.2371
52wk Range 0.2026 - 1.550
Shares Outstanding 1,535,653,620
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Get insights into the top gainers and losers of Thursday's after-hours session.
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
Here are the top movers in Thursday's session.
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
Via Chartmill

Performance

YTD
-67.0%
-67.0%
1 Month
-61.9%
-61.9%
3 Month
-62.8%
-62.8%
6 Month
-78.3%
-78.3%
1 Year
-86.0%
-86.0%

More News

Read More
Top movers in Thursday's session
Via Chartmill
Demystifying Adaptimmune Therapeutics: Insights From 4 Analyst Reviews
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
An Overview of Adaptimmune Therapeutics's Earnings
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Which stocks are gapping on Thursday?
Via Chartmill
Dow Gains Over 100 Points; Accenture Shares Plunge After Q2 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Adaptimmune Provides Q4 and Full Year 2024 Business Update
Via Newsfile
Earnings Scheduled For March 20, 2025
Via Benzinga
Adaptimmune to Report Full Year and Q4 2024 Financial and Business Updates on Thursday, March 20, 2025
Via Newsfile
Adaptimmune to Participate in the Guggenheim Securities SMID Cap Biotech Conference February 6, 2025
Via Newsfile
Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)
Via Newsfile
Exposures Product Safety
Adaptimmune Announces Changes to its Executive Leadership Team Based in The UK
Via Newsfile
Topics Initial Public Offering
Exposures Securities Market
First Patient Treated with Adaptimmune's TECELRA(R) (afamitresgene autoleucel)
Via Newsfile
Adaptimmune Reports Q3 2024 Financial and Business Updates
Via Newsfile
Adaptimmune's Lete-cel Achieves Primary Endpoint in Pivotal Trial
Via Newsfile
Adaptimmune to Participate in Scientific and Medical Conferences this November and December
Via Newsfile
Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024
Via Newsfile
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
From Virtual Investor Conferences
Via GlobeNewswire
Adaptimmune to Participate in Two Bank Conferences this September
Via Newsfile
ADAP Stock Earnings: Adaptimmune Therapeutics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Adaptimmune Reports Q2 2024 Financial and Business Updates
Via Newsfile
Exposures Product Safety

Frequently Asked Questions

Is Adaptimmune Therapeutics plc - American Depositary Shares publicly traded?
Yes, Adaptimmune Therapeutics plc - American Depositary Shares is publicly traded.
What exchange does Adaptimmune Therapeutics plc - American Depositary Shares trade on?
Adaptimmune Therapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Adaptimmune Therapeutics plc - American Depositary Shares?
The ticker symbol for Adaptimmune Therapeutics plc - American Depositary Shares is ADAP on the Nasdaq Stock Market
What is the current price of Adaptimmune Therapeutics plc - American Depositary Shares?
The current price of Adaptimmune Therapeutics plc - American Depositary Shares is 0.2060
When was Adaptimmune Therapeutics plc - American Depositary Shares last traded?
The last trade of Adaptimmune Therapeutics plc - American Depositary Shares was at 03/28/25 04:00 PM ET
What is the market capitalization of Adaptimmune Therapeutics plc - American Depositary Shares?
The market capitalization of Adaptimmune Therapeutics plc - American Depositary Shares is 316.34M
How many shares of Adaptimmune Therapeutics plc - American Depositary Shares are outstanding?
Adaptimmune Therapeutics plc - American Depositary Shares has 316M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.